Miras-amanat-e19601:04:57 Min -

Seizures that continue or relapse 24 hours after the administration of intravenous anesthetic treatment. 3. Clinical Findings

This study (e19601) provides a foundational theoretical basis for establishing effective mutation and symptom prediction models in neurological care. By defining the relationship between the duration of seizures (T1/T2 times) and patient outcomes, it offers clinicians a clearer roadmap for aggressive intervention in AE-related status epilepticus. Miras-Amanat-E19601:04:57 Min

Early initiation of immunotherapy is the most reliable predictor of a positive clinical outcome. Seizures that continue or relapse 24 hours after